• Article
  • Oct 21 2021

This year’s symposium will explore the legal and historical factors that have contributed to the current state of wealth disparity in the United States that falls largely along racial lines.

  • Article
  • Oct 19 2021

Conference sessions will address key industry topics. Attendees will also earn a certificate of continuing education for their participation.  

  • Article
  • Oct 19 2021

The Center for Applied Energy Research (CAER) received $1.3 million from the U.S. Department of Energy’s National Energy Technology Laboratory for development of new carbon capturing technology.

  • Article
  • Oct 18 2021

UK Board of Trustees on Friday endorsed an institutional strategic plan that focuses squarely on one overarching goal — how UK can advance the Commonwealth.

  • Article
  • Oct 18 2021

Three alumni and one faculty member were inducted into the University of Kentucky College of Arts and Sciences Hall of Fame at a ceremony on campus this past Friday.

  • Article
  • Oct 14 2021

Two innovation programs led by UK are receiving a part of the U.S. Small Business Administration's (SBA) $5.4 million in prizes to support inclusive entrepreneurship in the innovation ecosystem.

  • Article
  • Oct 13 2021

A recent study conducted by University of Kentucky College of Social Work researcher Keith J. Watts, Ph.D., discusses the social construction of masculinity and the implications it has on the mental health of gay Black men.

  • Article
  • Oct 13 2021

The University of Kentucky J. David Rosenberg College of Law will host its second daylong Breonna Taylor Symposium beginning 9 a.m. Saturday, Oct. 16, in the G. Chad Perry III Grand Courtroom in the law building.

  • Article
  • Oct 12 2021

UK researchers studied pandemic-related impacts to food systems including changes in consumer purchasing behaviors, pandemic responses of different food system sectors, innovations and agency support.

  • Article
  • Oct 11 2021

The University of Kentucky is a site for KidCOVE, a national trial by Moderna to test the safety and effectiveness of its COVID-19 vaccine in children. The vaccine may protect young children 6 months to those under 12 years of age if they come into contact with the SARS-CoV-2 virus.